Cingulate therapeutics headquarters
WebCingulate Therapeutics has raised a total of $7.6M in funding over 3 rounds. Their latest funding was raised on Jul 11, 2024 from a Venture - Series Unknown round. Cingulate Therapeutics is registered under the ticker NASDAQ:CING . Their stock opened with $6.00 in its Dec 8, 2024 IPO. WebJul 11, 2024 · Jul 11, 2024. Updated Jul 11, 2024, 2:54pm CDT. Cingulate Therapeutics LLC, a Kansas City, Kan., pharmaceutical startup, received a big equity investment and …
Cingulate therapeutics headquarters
Did you know?
WebMar 30, 2024 · EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML: 10 Mar 2024: 10-K: Annual report which provides a comprehensive overview of the company for the past year WebMar 10, 2024 · KANSAS CITY, Kan., March 10, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug...
WebMr. Peter Werth serves as Board Member at Cingulate Therapeutics. He is the Founder and also serves as Chief Executive Officer at Werth Ventures. He serves as Board Member at Alopexx Enterprises. He is the Owner & serves as the Chief Executive Officer & President at Chemwerth. He also served as a board member at InnoPharma. WebJun 15, 2024 · KANSAS CITY, Kan., June 15, 2024 /PRNewswire/ -- Cingulate Therapeutics, LLC, a privately held clinical stage biopharmaceutical company focused on...
WebCingulate is headquartered in Kansas City. For more information visit Cingulate.com. Forward-Looking Statements This press release contains certain forward-looking statements, including those relating to the use of proceeds and other statements that are predictive in nature. WebJun 15, 2024 · The new Kansas City location is at 1901 Olathe Blvd. in Kansas City, KS. About Cingulate Therapeutics Cingulate Therapeutics, LLC is a privately held clinical stage biopharmaceutical...
WebWhere is Cingulate Therapeutics 's headquarters? Cingulate Therapeutics is located in Morristown, New Jersey, United States. Who …
WebCingulate Therapeutics Primary Sponsor contact: Holly Mitzel Cingulate Therapeutics 1901 W. 47th Place, Suite 310 Kansas City, KS 66205 E: [email protected] P: 913-942-2304 Secondary Sponsor contact: Matt Brams, MD Cingulate Therapeutics 1901 W. 47th Place, Suite 310 Kansas City, KS … the purpose of extended ascii character setsWebCingulate Inc. 1,061 followers. 2mo. Today we announce our Q3 2024 financial results and provided a clinical and business update, including updated study timelines for our lead … the purpose of exerting social control is toWebAmendment to Employment Agreement, effective April 1, 2024, between Cingulate Therapeutics LLC and Raul R. Silva Cingulate Inc. Reports First Quarter 2024 Results and Provides Clinical and Business Update Announcement of First Subject Dosing for Anxiety Candidate CTx-2103 to Extend the Application of the Precision Timed Release™ … the purpose of eyepacs photography is toWebDec 8, 2024 · Cingulate Inc. is a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to … signify movements cheerfulness and continuityWebDec 8, 2024 · Cingulate Therapeutics (CTx) is a privately held, clinical-stage biopharmaceutical company focused on the development of products for the treatment … signify mountain top paWebJun 15, 2024 · Cingulate Therapeutics, LLC is a privately held clinical stage biopharmaceutical company focused on the development of new and innovative products … signify multione downloadWebCurt Medeiros' role at Cingulate Therapeutics is Independent Director, Board of Directors. What is Curt Medeiros' email address? ... What is Curt Medeiros' HQ phone number? Curt Medeiros' HQ phone number is +1 913-942-2300. What industry does Curt … signify mylighting log on